Gut-brain axis crosstalk in patients with Alzheimer's disease and high body mass index: Gut dysbiosis,blood-brain barrier disruption,and neuroinflammation
Restricted accessResearch articleFirst published online 2026
Gut-brain axis crosstalk in patients with Alzheimer's disease and high body mass index: Gut dysbiosis,blood-brain barrier disruption,and neuroinflammation
Accumulating evidence indicates that body mass index (BMI) is related to Alzheimer's disease (AD).
Objective
This study aimed to investigate the impact of high BMI on cognitive function in AD patients and potential mechanisms involving gut dysbiosis, blood-brain barrier (BBB) disruption, and neuroinflammation in brain.
Methods
A total of 50 AD patients were recruited and divided into AD with normal BMI (AD-nBMI) and AD with high BMI (AD-hBMI) groups. Cognitive function was assessed, the levels of BBB variables, neuroinflammatory factors, and AD biomarkers in cerebrospinal fluid (CSF) were measured, gut microbiota and metabolites were analyzed using 16S ribosomal ribonucleic acid gene sequencing and gas chromatography-mass spectrometry analysis, and the correlations among gut microbiota and metabolites, BBB variables, and neuroinflammatory factors in CSF were analyzed.
Results
AD-hBMI group exhibited impaired overall cognition, elevated CSF levels of zonula occludens-1 (ZO-1) and occludin (OCLN) (BBB disruption), and increased CSF levels of nitric oxide (NO) and hydroxyl radical (·OH) (neuroinflammation) compared with AD-nBMI group. Correlation analyses revealed that BMI was positively associated with impaired cognition, CSF levels of OCLN and NO in AD patients. AD-hBMI group displayed a unique gut dysbiosis pattern characterized by the alterations in specific metabolite levels. In AD-hBMI group, elevated thioridazine, 4-hydroxybenzaldehyde, and N-acetylleucine were positively correlated with ZO-1 level in CSF, reduced acesulfame and undecanoic acid were negatively correlated with OCLN level in CSF, and elevated (S)-S-methylcysteine sulfoxide was positiveiy correlated with both ZO-1 and OCLN levels in CSF. Elevated thioridazine and medroxyprogesterone were positively correlated with NO level in CSF, and decreased butyric acid was negatively correlated with ·OH level in CSF.
Conclusions
High BMI may accelerate gut dysbiosis, leading to disrupted BBB, enhanced neuroinflammation, and ultimately accelerated cognitive impairment in AD patients.
LongJMHoltzmanDM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell2019; 179: 312–339.
3.
BellenguezCKüçükaliFJansenIE, et al.New insights into the genetic etiology of Alzheimer's disease and related dementias. Nat Genet2022; 54: 412–436.
4.
BarnesDEYaffeK. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol2011; 10: 819–828.
5.
BischofGNParkDC. Obesity and aging: consequences for cognition, brain structure, and brain function. Psychosom Med2015; 77: 697–709.
6.
DyeLBoyleNBChampC, et al.The relationship between obesity and cognitive health and decline. Proc Nutr Soc2017; 76: 443–454.
7.
WoodieLBlytheS. The differential effects of high-fat and high-fructose diets on physiology and behavior in male rats. Nutr Neurosci2018; 21: 328–336.
8.
MengrAStrnadováVStrnadŠ, et al.Feeding high-fat diet accelerates development of peripheral and central insulin resistance and inflammation and worsens AD-like pathology in APP/PS1 mice. Nutrients2023; 15: 3690.
9.
WhitmerRAGustafsonDRBarrett-ConnorE, et al.Central obesity and increased risk of dementia more than three decades later. Neurology2008; 71: 1057–1064.
10.
JagustWHarveyDMungasD, et al.Central obesity and the aging brain. Arch Neurol2005; 62: 1545–1548.
11.
BalasubramanianPKissTTarantiniS, et al.Obesity-induced cognitive impairment in older adults: a microvascular perspective. Am J Physiol Heart Circ Physiol2021; 320: H740–H761.
12.
BuieJJWatsonLSSmithCJ, et al.Obesity-related cognitive impairment: the role of endothelial dysfunction. Neurobiol Dis2019; 132: 104580.
13.
de PaulaGCBrunettaHSEngelDF, et al.Hippocampal function is impaired by a short-term high-fat diet in mice: increased blood-brain barrier permeability and neuroinflammation as triggering events. Front Neurosci2021; 15: 734158.
14.
HaseloffRFDithmerSWinklerL, et al.Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects. Semin Cell Dev Biol2015; 38: 16–25.
15.
JiaoXHePLiY, et al.The role of circulating tight junction proteins in evaluating blood brain barrier disruption following intracranial hemorrhage. Dis Markers2015; 2015: 860120.
16.
ZhuJCSiMYLiYZ, et al.Circulating tight junction proteins mirror blood-brain barrier integrity in leukaemia central nervous system metastasis. Hematol Oncol2017; 35: 365–373.
17.
TucsekZTothPSosnowskaD, et al.Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease. J Gerontol A Biol Sci Med Sci2014; 69: 1212–1226.
18.
Pallebage-GamarallageMLamVTakechiR, et al.Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents. Lipids Health Dis2012; 11: 117.
19.
Neyra ChaucaJMRobles MartinezGG. Histological and functional breakdown of the blood-brain barrier in Alzheimer's disease: a multifactorial intersection. Neurol Int2025; 17: 166.
20.
CryanJFO'RiordanKJCowanCSM, et al.The microbiota-gut-brain axis. Physiol Rev2019; 99: 1877–2013.
21.
DonosoFCryanJFOlavarría-RamírezL, et al.Inflammation, lifestyle factors, and the microbiome-gut-brain axis: relevance to depression and antidepressant action. Clin Pharmacol Ther2023; 113: 246–259.
22.
ShiHYuYLinD, et al.β-glucan attenuates cognitive impairment via the gut-brain axis in diet-induced obese mice. Microbiome2020; 8: 143.
23.
ShiHWangQZhengM, et al.Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice. J Neuroinflammation2020; 17: 77.
24.
SherwinEBordensteinSRQuinnJL, et al.Microbiota and the social brain. Science2019; 366: eaar2016.
25.
ChenCLiaoJXiaY, et al.Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut2022; 71: 2233–2252.
26.
JackCRJrBennettDABlennowK, et al.NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement2018; 14: 535–562.
27.
ZhouBF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci2002; 15: 83–96.
28.
CockrellJRFolsteinMF. Mini-mental state examination (MMSE). Psychopharmacol Bull1988; 24: 689–692.
29.
YuJLiJHuangX. The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study. BMC Psychiatry2012; 12: 156.
ZhangWChenYChenN. Body mass index and trajectories of the cognition among Chinese middle and old-aged adults. BMC Geriatr2022; 22: 613.
32.
YangYShieldsGSGuoC, et al.Executive function performance in obesity and overweight individuals: a meta-analysis and review. Neurosci Biobehav Rev2018; 84: 225–244.
33.
LinLBasuRChatterjeeD, et al.Disease-associated astrocytes and microglia markers are upregulated in mice fed high fat diet. Sci Rep2023; 13: 12919.
34.
PatelYWooAShiS, et al.Obesity and the cerebral cortex: underlying neurobiology in mice and humans. Brain Behav Immun2024; 119: 637–647.
35.
LanannaBVMcKeeCAKingMW, et al.Chi3l1/YKL-40 is controlled by the astrocyte circadian clock and regulates neuroinflammation and Alzheimer's disease pathogenesis. Sci Transl Med2020; 12: eaax3519.
36.
Keren-ShaulHSpinradAWeinerA, et al.A unique microglia type associated with restricting development of Alzheimer's disease. Cell2017; 169: 1276–1290.e17.
37.
FilipelloFYouSFMirfakharFS, et al.Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation. Acta Neuropathol2023; 145: 749–772.
38.
PiccioLDemingYDel-AguilaJL, et al.Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status. Acta Neuropathol2016; 131: 925–933.
39.
Suárez-CalvetMMorenas-RodríguezEKleinbergerG, et al.Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid- β pathology. Mol Neurodegener2019; 14: 1.
40.
EwersMFranzmeierNSuárez-CalvetM, et al.Increased CSF soluble TREM2 is associated with ameliorated longitudinal cognitive and clinical decline in Alzheimer's disease. Alzheimers Dement2019; 15: P917.
41.
LiangZGongXZhaoY, et al.Long-term high-fat diet consumption aggravates β-amyloid deposition and tau pathology accompanied by microglial activation in an Alzheimer's disease model. Mol Nutr Food Res2024; 68: e2300669.
42.
MarschallingerJIramTZardenetaM, et al.Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci2020; 23: 194–208.
43.
AlkhalifaAEAl-GhraiybahNFOdumJ, et al.Blood-brain barrier breakdown in Alzheimer's disease: mechanisms and targeted strategies. Int J Mol Sci2023; 24: 16288.
44.
KalariaRN. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev2010; 68: S74–S87.
45.
KarczewskiJZielińskaAStaszewskiR, et al.Obesity and the brain. Int J Mol Sci2022; 23: 6145.
46.
LiuPWuLPengG, et al.Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun2019; 80: 633–643.
47.
LasseniusMIPietiläinenKHKaartinenK, et al.Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care2011; 34: 1809–1815.
48.
WangJWDCWangYD. The relationship between gut microbiota and inflammatory diseases: the role of macrophages. Front Microbiol2020; 11: 1065.
49.
ChandraSSisodiaSSVassarRJ. The gut microbiome in Alzheimer's disease: what we know and what remains to be explored. Mol Neurodegener2023; 18: 9.
50.
PalmasVPisanuSMadauV, et al.Gut microbiota markers associated with obesity and overweight in Italian adults. Sci Rep2021; 11: 5532.
51.
LamichhaneGLiuJLeeSJ, et al.Curcumin mitigates the high-fat high-sugar diet-induced impairment of spatial memory, hepatic metabolism, and the alteration of the gut microbiome in Alzheimer's disease-induced (3xTg-AD) mice. Nutrients2024; 16: 261.
52.
ZhaoYJaberVRPogueAI, et al.Lipopolysaccharides (LPSs) as potent neurotoxic glycolipids in Alzheimer's disease (AD). Int J Mol Sci2022; 23: 12436.
53.
ZhaoYHeCHuS, et al.Anti-oxidative stress and cognitive improvement of a semi-synthetic isoorientin-based GSK-3β inhibitor in rat pheochromocytoma cell PC12 and scopolamine-induced AD model mice via AKT/GSK-3β/Nrf2 pathway. Exp Neurol2024; 380: 114881.
54.
YangYGarcía-CruzadoMZengH, et al.LPS Priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease. Brain Behav Immun2023; 113: 228–247.
55.
RefoloLMSnyderHLigginsC, et al.Common Alzheimer's disease research ontology: national institute on aging and Alzheimer's association collaborative project. Alzheimers Dement2012; 8: 372–375.
56.
TangHWuLChenX, et al.Paeoniflorin improves functional recovery through repressing neuroinflammation and facilitating neurogenesis in rat stroke model. PeerJ2021; 9: e10921.
57.
LiDBaiXJiangY, et al.Butyrate alleviates PTZ-induced mitochondrial dysfunction, oxidative stress and neuron apoptosis in mice via Keap1/Nrf2/HO-1 pathway. Brain Res Bull2021; 168: 25–35.
